title: Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
abstract: Previous studies have failed to detect an interaction between monomeric soluble CD4 (sCD4) and class II major histocompatibility complex (MHC) proteins, suggesting that oligomerization of CD4 on the cell surface may be required to form a stable class II MHC binding site. To test this possibility, we transfected the F43I CD4 mutant, which is incapable of binding to class II MHC or human immunodeficiency virus (HIV) gp120, into COS-7 cells together with wild-type CD4 (wtCD4). Expression of F43I results in a dominant negative effect: no class II MHC binding is observed even though wtCD4 expression is preserved. Apparently, F43I associates with wtCD4 oligomers and interferes with the formation of functional class II MHC binding structures. In contrast, F43I does not affect the binding of gp120 to wtCD4, implying that gp120 binds to a CD4 monomer. By production and characterization of chimeric CD4 molecules, we show that domains 3 and/or 4 appear to be involved in oligomerization. Several models of the CD4-class II MHC interaction are offered, including the possibility that one or two CD4 molecules initially interact with class II MHC dimers and further associate to create larger complexes important for facilitating T-cell receptor crosslinking.
authors.affiliation: Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Sakihama
authors.forename: A
authors.initials: A
authors.lastname: Smolyar
authors.forename: E L
authors.initials: EL
authors.lastname: Reinherz
mesh_terms: D000818:Animals; D015704:CD4 Antigens / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D002522:Chlorocebus aethiops; D005434:Flow Cytometry; D015699:HIV Envelope Protein gp120 / Q000276:immunology / Q000378:metabolism*; D006681:HLA-D Antigens / Q000276:immunology / Q000378:metabolism*; D000949:Histocompatibility Antigens Class II / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation; D046911:Macromolecular Substances; D018448:Models, Immunological; D011485:Protein Binding; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D006681:HLA-D Antigens; D000949:Histocompatibility Antigens Class II; D046911:Macromolecular Substances; D011994:Recombinant Proteins